Abstract
Complicated urinary tract infection (cUTI) is a frequent cause of morbidity. In this multinational retrospective cohort study, we aimed to demonstrate risk factors for enterococcal UTI. Univariate and multivariate analyses of risk factors for enterococcal infection were performed. Among 791 hospitalized patients with cUTI, enterococci accounted for approximately 10% of cases (78/791). Risk factors for enterococcal UTI in multivariable analysis were male gender, age range of 55–75 years, catheter-associated UTI, and urinary retention. This information may assist treating physicians in their decision-making on prescribing empiric anti-enterococcus treatment to hospitalized patients presenting with cUTI and thus improve clinical outcomes.
Similar content being viewed by others
Code availability
Not applicable
References
Czaja CA, Scholes D, Hooton TM, Stamm WE (2007) Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis Off Publ Infect Dis Soc Am 45(3):273–280. https://doi.org/10.1086/519268
Giannakopoulos X, Sakkas H, Ragos V et al (2019) Impact of enterococcal urinary tract infections in immunocompromised - neoplastic patients. J BUON 24(5):1768–1775
Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13(5):269–284. https://doi.org/10.1038/nrmicro3432
Levison ME, Kaye D (2013) Treatment of complicated urinary tract infections with an emphasis on drug-resistant gram-negative uropathogens. Curr Infect Dis Rep 15(2):109–115. https://doi.org/10.1007/s11908-013-0315-7
Fisher JF, Kavanagh K, Sobel JD, Kauffman CA, Newman CA (2011) Candida urinary tract infection: pathogenesis. Clin Infect Dis Off Publ Infect Dis Soc Am 52(Suppl 6):S437–S451. https://doi.org/10.1093/cid/cir110
Chen YH, Ko WC, Hsueh PR (2013) Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections. Expert Opin Pharmacother 14(5):587–596. https://doi.org/10.1517/14656566.2013.778827
Jacobsen SM, Stickler DJ, Mobley HLT, Shirtliff ME (2008) Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 21(1):26–59. https://doi.org/10.1128/CMR.00019-07
Maki DG, Tambyah PA (2001) Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 7(2):342–347. https://doi.org/10.3201/eid0702.010240
Ramsey AM, Zilberberg MD (2009) Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol 30(2):184–186. https://doi.org/10.1086/593956
Agudelo Higuita NI, Huycke MM (2014) Enterococcal Disease, Epidemiology, and Implications for Treatment. In: Gilmore MS, Clewell DB, Ike Y, Shankar N, eds. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection. Massachusetts Eye and Ear Infirmary. http://www.ncbi.nlm.nih.gov/books/NBK190429/. Accessed 28 Dec 2019
Data from the ECDC Surveillance Atlas - Antimicrobial resistance. European Centre for Disease Prevention and Control. https://www.ecdc.europa.eu/en/antimicrobial-resistance/surveillance-and-disease-data/data-ecdc. Accessed 5 June 2020
Noskin GA, Peterson LR, Warren JR (1995) Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis 20:296–301. https://doi.org/10.1093/clinids/20.2.296
Patterson JE, Sweeney AH, Simms M, Carley N, Mangi R, Sabetta J, Lyons RW (1995) An analysis of 110 serious enterococcal infections. Epidemiology, antibiotic susceptibility, and outcome. Medicine (Baltimore) 74:191–200. https://doi.org/10.1097/00005792-199507000-00003
McBride SJ, Upton A, Roberts SA (2010) Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review. Eur J Clin Microbiol Infect Dis 29:107–114. https://doi.org/10.1007/s10096-009-0830-5
Garrison RN, Fry DE, Berberich S, Polk HC (1982) Enterococcal bacteremia: clinical implications and determinants of death. Ann Surg 196:43–47. https://doi.org/10.1097/00000658-198207000-00010
Gray J, Marsh PJ, Stewart D, Pedler SJ (1994) Enterococcal bacteraemia: a prospective study of 125 episodes. J Hosp Infect 27:179–186. https://doi.org/10.1016/0195-6701(94)90125-2
Graninger W, Ragette R (1992) Nosocomial bacteremia due to Enterococcus faecalis without endocarditis. Clin Infect Dis 15:49–57. https://doi.org/10.1093/clinids/15.1.49
Eliakim-Raz N, Babitch T, Shaw E et al (2019) Risk factors for treatment failure and mortality among hospitalized patients with complicated urinary tract infection: a multicenter retrospective cohort study (RESCUING Study Group). Clin Infect Dis 68(1):29–36. https://doi.org/10.1093/cid/ciy418
Jombo GT, Emanghe UE, Amefule EN, Damen JG (2011) Urinary tract infections at a Nigerian university hospital: Causes, patterns and antimicrobial susceptibility profile. J Microbiol Antimicrob 3(6):153–159
Mathai D, Jones RN, Pfaller MA (2001) SENTRY Participant Group North America. Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis 40(3):129–136. https://doi.org/10.1016/s0732-8893(01)00254-1
Bouza E, San Juan R, Muñoz P, Voss A, Kluytmans J (2001) Co-operative group of the european study group on nosocomial infections. A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections. Clin Microbiol Infect 7(10):523–531. https://doi.org/10.1046/j.1198-743x.2001.00326.x
Bouza E, San Juan R, Muñoz P, Voss A, Kluytmans J (2001) Co-operative group of the european study group on nosocomial infections. A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study Group on Nosocomial Infection. Clin Microbiol Infect 7(10):532–542. https://doi.org/10.1046/j.1198-743x.2001.00324.x
Madrazo M, Esparcia A, Alberola J et al (2020) Predictive factors for Enterococcus faecalis in complicated community-acquired urinary tract infections in older patients. Geriatr Gerontol Int 20(3):183–186. https://doi.org/10.1111/ggi.13856
Kajihara T, Nakamura S, Iwanaga N et al (2015) Clinical characteristics and risk factors of enterococcal infections in Nagasaki, Japan: a retrospective study. BMC Infect Dis 15. https://doi.org/10.1186/s12879-015-1175-6
Pinholt M, Ostergaard C, Arpi M et al (2014) Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: a population-based cohort study. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 20(2):145–151. https://doi.org/10.1111/1469-0691.12236
Billington EO, Phang SH, Gregson DB et al (2014) Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study. Int J Infect Dis IJID Off Publ Int Soc Infect Dis 26:76–82. https://doi.org/10.1016/j.ijid.2014.02.012
Saia RS, Garcia FM, Cárnio EC (2015) Estradiol protects female rats against sepsis induced by Enterococcus faecalis improving leukocyte bactericidal activity. Steroids. 102:17–26. https://doi.org/10.1016/j.steroids.2015.06.016
Cornia PB, Takahashi TA, Lipsky BA (2006) The microbiology of bacteriuria in men: a 5-year study at a Veterans’ Affairs hospital. Diagn Microbiol Infect Dis 56(1):25–30. https://doi.org/10.1016/j.diagmicrobio.2006.03.008
Gomila A, Carratalà J, Eliakim-Raz N et al (2019) Clinical outcomes of hospitalised patients with catheter-associated urinary tract infection in countries with a high rate of multidrug-resistance: the COMBACTE-MAGNET RESCUING study. Antimicrob Resist Infect Control 8:198. https://doi.org/10.1186/s13756-019-0656-6
Zielinski MD, Kuntz MM, Polites SF et al (2015) A prospective analysis of urinary tract infections among elderly trauma patients. J Trauma Acute Care Surg 79(4):638–642. https://doi.org/10.1097/TA.0000000000000796
Funding
This research project receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115523 | 115620 | 115737 | 777362 resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution. The research leading to these results was conducted as part of the COMBACTE-MAGNET consortium. For further information please refer to www.COMBACTE.com.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Ethical approval
The study was approved by the local ethics board of each participating center. Data processing was anonymized and complied with local data protection legislation and with the European Directive on the Privacy of Data (95/46/EC).
Competing interests
The authors declare that they have no competing interests.
Informed consent
Informed consent is not required because of the retrospective design of this study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix
Appendix
Rights and permissions
About this article
Cite this article
Turjeman, A., Babich, T., Pujol, M. et al. Risk factors for enterococcal urinary tract infections: a multinational, retrospective cohort study. Eur J Clin Microbiol Infect Dis 40, 2005–2010 (2021). https://doi.org/10.1007/s10096-021-04207-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-021-04207-4